Form 4: ANI Pharmaceuticals Executive Gutwerg Sells Shares for Tax Obligations
SEC Form 4 Filing
Ori Gutwerg, SVP of Generics at ANI Pharmaceuticals, disposed of shares to cover tax obligations related to the vesting of restricted stock.
Summary
- On February 29, 2024, Ori Gutwerg, SVP of Generics at ANI Pharmaceuticals, disposed of 1,570 shares of common stock.
- The shares were sold at a price of $67.67 per share.
- This transaction was to cover tax obligations related to the vesting of 4,342 shares of restricted stock.
- Following the transaction, Gutwerg directly owns 82,706 shares of ANI Pharmaceuticals.
- The transaction was exempt under Rule 16(b)-3.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reflects a routine transaction for tax purposes.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to ensure transparency of trading activity by corporate insiders. This filing indicates that an executive disposed of shares, likely to cover tax obligations.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a routine sale to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Date of the transaction where shares were disposed of. |
| 03/01/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.